Cargando…

Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand

PURPOSE: Given the lack of economic evaluation study of molecular testing in Thailand, this study aimed to evaluate the cost-utility of molecular testing algorithms including Xpert MTB/RIF and the loop-mediated isothermal amplification (TB-LAMP) in the general population suspected of having pulmonar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitpim, Natthakan, Jittikoon, Jiraphun, Udomsinprasert, Wanvisa, Mahasirimongkol, Surakameth, Chaikledkaew, Usa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819700/ https://www.ncbi.nlm.nih.gov/pubmed/35140485 http://dx.doi.org/10.2147/CEOR.S350606

Ejemplares similares

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Economic impact of medical genetic testing on clinical applications in Thailand
por: Jittikoon, Jiraphun, et al.
Publicado: (2020)

Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2021)

GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury
por: Chanhom, Noppadol, et al.
Publicado: (2020)

Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients
por: Chanhom, Noppadol, et al.
Publicado: (2021)

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV
por: Turongkaravee, Saowalak, et al.
Publicado: (2022)

Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2020)

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand
por: Rochanathimoke, Onwipa, et al.
Publicado: (2022)

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis
por: Yoopetch, Panida, et al.
Publicado: (2023)

Cartilage oligomeric matrix protein as a marker of progressive liver fibrosis in biliary atresia
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2021)

Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Clusterin exacerbates interleukin-1β-induced inflammation via suppressing PI3K/Akt pathway in human fibroblast-like synoviocytes of knee osteoarthritis
por: Ungsudechachai, Tachatra, et al.
Publicado: (2022)

Host genetic polymorphisms involved in long-term symptoms of COVID-19
por: Udomsinprasert, Wanvisa, et al.
Publicado: (2023)

The Association of HLA-B*35 and GSTT1 Genotypes and Hepatotoxicity in Thai People Living with HIV
por: Chanhom, Noppadol, et al.
Publicado: (2022)

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy
por: Turongkaravee, Saowalak, et al.
Publicado: (2021)

The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020)

Contact tracing for tuberculosis, Thailand
por: Imsanguan, Worarat, et al.
Publicado: (2020)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2021)

Risk for Prison-to-Community Tuberculosis Transmission, Thailand, 2017–2020
por: Miyahara, Reiko, et al.
Publicado: (2023)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

Genetics and genomics in Thailand: challenges and opportunities
por: Shotelersuk, Vorasuk, et al.
Publicado: (2014)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Peptide microarray-based identification of dormancy-associated Mycobacterium tuberculosis antigens inducing immune responses among latent tuberculosis infection individuals in Thailand
por: Hanthamrongwit, Jariya, et al.
Publicado: (2023)

Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
por: Sribhutorn, Apirak, et al.
Publicado: (2018)

Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014–2017
por: Nonghanphithak, Ditthawat, et al.
Publicado: (2021)

Revised nomenclature and SNP barcode for Mycobacterium tuberculosis lineage 2
por: Thawornwattana, Yuttapong, et al.
Publicado: (2021)

Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis
por: Kabir, Shaila, et al.
Publicado: (2021)

Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2021)

Predicting the risk of pulmonary tuberculosis based on the neutrophil-to-lymphocyte ratio at TB screening in HIV-infected individuals
por: Miyahara, Reiko, et al.
Publicado: (2019)

Homoplastic single nucleotide polymorphisms contributed to phenotypic diversity in Mycobacterium tuberculosis
por: Tantivitayakul, Pornpen, et al.
Publicado: (2020)

Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia
por: Mesfin, Mengiste M, et al.
Publicado: (2010)

Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis
por: Bai, Wenjing, et al.
Publicado: (2021)

Prevalence of Melioidosis in Patients with Suspected Pulmonary Tuberculosis and Sputum Smear Negative for Acid-Fast Bacilli in Northeast Thailand
por: Suntornsut, Pornpan, et al.
Publicado: (2013)

Distribution of Mycobacterium tuberculosis Lineages and Drug Resistance in Upper Myanmar
por: Phyu, Aye Nyein, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gemrcrcrqvsth5us0n6feglbui